XML 59 R44.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of significant accounting policies and basis of presentation - Narrative (Detail)
12 Months Ended
Dec. 31, 2022
USD ($)
segment
shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2020
USD ($)
Nov. 04, 2021
USD ($)
Nov. 03, 2021
shares
Restricted Cash and Cash Equivalents Items [Line Items]          
Transfers from bluebird bio $ 0 $ 354,889,000 $ 90,054,000    
Net assets       $ 384,500,000  
Number of operating segments | segment 1        
Accumulated goodwill impairment loss $ 0        
Interest income $ 2,932,000 $ 88,000 0    
Common stock, shares outstanding (in shares) | shares 37,928,000 23,585,000     0
Restricted cash included in restricted cash and other non-current assets $ 33,026,000 $ 32,852,000 $ 0    
Letter of credit          
Restricted Cash and Cash Equivalents Items [Line Items]          
Restricted cash included in restricted cash and other non-current assets $ 30,000,000